NCT04018001View on ClinicalTrials.gov

Comparative Analysis of Adherence and Effectiveness Outcomes Between Rheumatoid Arthritis (RA) Patients Treated With Tofacitinib Modified Release (MR)

CompletedOBSERVATIONAL
Enrollment

1,057

Participants

Timeline

Start Date

April 12, 2019

Primary Completion Date

April 25, 2019

Study Completion Date

April 25, 2019

Conditions
Rheumatoid Arthritis
Trial Locations (1)

10017

Pfizer, New York

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT04018001 - Comparative Analysis of Adherence and Effectiveness Outcomes Between Rheumatoid Arthritis (RA) Patients Treated With Tofacitinib Modified Release (MR) | Biotech Hunter | Biotech Hunter